Evolution winning in bacteria vs antibiotics arms race

November 19, 2013

Science is running out of new ways to attack harmful bacteria, while drug companies are abandoning antibiotic research and development, according to a University of Adelaide drug expert.

Speaking during Antibiotic Awareness Week (18-24 November), Dr Ian Musgrave from the University's School of Medical Sciences says whenever a new antibiotic is developed, evolve to become resistant within a relatively short period of time.

"There's no doubt that evolution is winning the antibiotics arms race," says Dr Musgrave, a Senior Lecturer in Pharmacology.

"Bacteria are very good at mutating and developing resistance. What's more, bacteria can easily swap DNA, so these resistance mutations can be effectively 'downloaded' from one bacteria to the next. Bacteria can aquire multiple resistance genes this way."

He says science is now falling behind. "We can attack the metabolic pathways bacteria use, we can attack their DNA replication, or we can bust open their cell walls, but each time scientists develop something new, bacteria will evolve so that the same drugs might not be as effective in the following years. It's a vicious cycle, and we can't continue on it," he says.

Dr Musgrave says many are giving up on antibiotics. "Antibiotic research and development is crashing - it doesn't seem to be as profitable any more and there's a lack of new drugs coming onto the market," he says.

The use of multi-drug cocktails, a method employed for HIV patients, could help. This approach attacks bacteria in different ways all at the same time. "However, this kind of treatment is likely to be expensive for the patient and could lead to additional adverse drug events," Dr Musgrave says.

He says one of the best ways to prevent bacteria from developing resistance is for patients to take their full dosage of antibiotics as prescribed by their doctor.

"Many people start taking antibiotics but then they feel better and don't see the point in taking them any more. The point is, they need to kill off all the harmful bacteria. If they don't do this, the can rapidly build up again and become resistant to the drug."

He says GPs should also make sure they're not prescribing antibiotics for uncomplicated viral conditions.

Antibiotic Awareness Week is a global initative to help people learn about and preserve these life-saving medicines.

"Anything we can do to limit the amount of unnecessary anitbiotics in the community will be helpful in preventing resistance," Dr Musgrave says. "For example, the use of in agriculture is a controversial issue, and this can lead to resistant strains of disease that pass from animals to humans."

Explore further: Antibiotics – friend and foe?

Related Stories

Antibiotics – friend and foe?

November 18, 2013
European Antibiotic Awareness Day is marked on the 18th November every year. This year in Norway, a seminar for health care providers about antibiotic use and resistance will be held, as well as several local events around ...

3Qs: The effect of antibiotic resistant bacteria

October 2, 2013
Last month, the Centers for Disease Control and Prevention released a report titled Antibiotic resistance threats in the United States, 2013, that served as a first-ever snapshot of the effect antibiotic resistant microbes ...

'Cycling' antibiotics might help combat resistance, study suggests

September 26, 2013
(HealthDay)—Doctors might be able to overcome antibiotic-resistant bacteria by swapping out the antibiotics used to treat a patient, providing a "one-two" punch that keeps the germs reeling, a new Danish study suggests.

New hypothesis: Why bacteria are becoming increasingly more resistant to antibiotics

March 7, 2013
According to his theory, bacteria that are non-resistant to antibiotics acquire said resistance accidentally because they take up the DNA of others that are resistant, due to the stress to which they are subjected.

'Stressed' bacteria become resistant to antibiotics

February 21, 2013
Bacteria become resistant to antibiotics when stressed, finds research published in BioMed Central's open access journal BMC Evolutionary Biology. In particular E. coli grown at high temperatures become resistant to rifampicin.

CDC sounds alarm on antibiotic-resistant bacteria

September 16, 2013
(HealthDay)—More than 2 million people come down with infections from antibiotic-resistant bacteria every year in the United States, leading to at least 23,000 deaths, according to a report released Monday by federal health ...

Recommended for you

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.